Evidence map›Paper›PMID 31992542›Full record

ArticleBMJ (Clinical research ed.)2020

To include or not include: renal dialysis policy in the era of universal health coverage.

Yot Teerawattananon, Saudamini Vishwanath Dabak, Levina Chandra Khoe, Diana Beatriz S Bayani, Wanrudee Isaranuwatchai

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Missing In-Center Hemodialysis Sessions among Patients with End Stage Renal Disease in Banda Aceh, Indonesia.International journal of environmental research and public health · 2021
    Article
  19. Distributional Cost-Effectiveness Analysis Comes of Age.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yot TeerawattananonHealth Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.
Saudamini Vishwanath DabakHealth Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand saudamini.d@hitap.net.
Levina Chandra KhoeDepartment of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Diana Beatriz S BayaniSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Wanrudee IsaranuwatchaiHealth Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health PolicyHealth Services AccessibilityKidney Failure, ChronicUniversal Health InsuranceDeveloping CountriesHealth Services Needs and DemandHumansPolicy MakingQuality ImprovementRenal Dialysis

Identifiers

PMID31992542
PMCPMC7190365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.